Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study
- DOI
- 10.1186/s12933-022-01572-y
- Published
- 2022-08-24
- Container
- Cardiovascular Diabetology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12933-022-01572-y,
title = {Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study},
author = {Marta Baviera and Andreana Foresta and Pierluca Colacioppo and Giulia Macaluso and Maria Carla Roncaglioni and Mauro Tettamanti and Ida Fortino and Stefano Genovese and Irene Caruso and Francesco Giorgino},
year = {2022},
journal = {Cardiovascular Diabetology},
doi = {10.1186/s12933-022-01572-y},
url = {https://doi.org/10.1186/s12933-022-01572-y}
}RIS
TY - JOUR TI - Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study AU - Marta Baviera AU - Andreana Foresta AU - Pierluca Colacioppo AU - Giulia Macaluso AU - Maria Carla Roncaglioni AU - Mauro Tettamanti AU - Ida Fortino AU - Stefano Genovese AU - Irene Caruso AU - Francesco Giorgino PY - 2022 JO - Cardiovascular Diabetology DO - 10.1186/s12933-022-01572-y UR - https://doi.org/10.1186/s12933-022-01572-y ER -
APA
Baviera, M., Foresta, A., Colacioppo, P., Macaluso, G., Roncaglioni, M. C., Tettamanti, M., Fortino, I., Genovese, S., Caruso, I., & Giorgino, F. (2022). Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-022-01572-y
Source records
- crossref · retrieved 2026-09-26T13:02:19.686Z